Investor Presentation
adj. ebitda reconciliation
AR
Loss from operations (GAAP)
Incremental costs to acquire cannabis inventory in business combination
all amounts in USD (in thousands)
Interest (within COGS)
Depreciation and amortization
Acquisition costs
Stock-based compensation, non-cash
Start-up costs¹
Other²
Gain on sale of Assets
Adjusted EBITDA
three months ended June 30
2021
(24,881)
2022
(24,797)
3,212
772
22,570
2,722
9,727
3,862
3,576
(2,000)
41,229
19,644
26,596
213
14,587
1,284
7,152
1,350
1,122
25,708
27,423
1) Costs to prepare a location for its intended use, including facilities not yet operating at scale. Start-up costs are expensed as incurred and are not indicative of ongoing operations
2) Other non-core costs including non-operating adjustments and non-cash inventory write-downs
CSE:AYR.A | OTC:AYRWF
six months ended June 30
2021
(33,249)
2022
(45,923)
5,731
1,252
43,810
4,173
20,088
6,511
5,499
(2,000)
79,333
39,141
32,388
457
22,064
4,422
15,376
2,973
1,408
46,700
45,839
19View entire presentation